NO965445L - Ny 4-imidazolidinonforbindelse, fremgangsmåte ved dens fremstilling og farmasöytiske sammensetninger inneholdende den - Google Patents

Ny 4-imidazolidinonforbindelse, fremgangsmåte ved dens fremstilling og farmasöytiske sammensetninger inneholdende den

Info

Publication number: NO965445L
Authority: NO; Norway
Prior art keywords: new; preparation; pharmaceutical compositions; compositions containing; imidazolidinone compound
Prior art date: 1995-12-21

Application number

NO965445A

Other languages

English (en)

Other versions

NO965445D0 (no

NO305753B1 (no

Inventor

Alex Cordi

Jean-Michel Lacoste

Mark Millan

Valerie Audinot

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-21

Filing date

1996-12-18

Publication date

1997-06-23

1996-12-18 Application filed by Adir filed Critical Adir

1996-12-18 Publication of NO965445D0 publication Critical patent/NO965445D0/no

1997-06-23 Publication of NO965445L publication Critical patent/NO965445L/no

1999-07-19 Publication of NO305753B1 publication Critical patent/NO305753B1/no

Links

-1 4-Imidazolidinone Compound Chemical class 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
PAQPVNMFUTZAOU-UHFFFAOYSA-N 3-hydroxyimidazolidin-4-one Chemical compound ON1CNCC1=O PAQPVNMFUTZAOU-UHFFFAOYSA-N 0.000 abstract 1
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 1
239000008098 formaldehyde solution Substances 0.000 abstract 1
VDBCTDQYMZSQFQ-UHFFFAOYSA-N glycine hydroxamate Chemical compound NCC(=O)NO VDBCTDQYMZSQFQ-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO965445A 1995-12-21 1996-12-18 Ny 4-imidazolidinonforbindelse, fremgangsmÕte ved dens fremstilling og farmas°ytiske sammensetninger inneholdende den NO305753B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9515223A FR2742748B1 (fr)	1995-12-21	1995-12-21	Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui le contiennent

Publications (3)

Publication Number	Publication Date
NO965445D0 NO965445D0 (no)	1996-12-18
NO965445L true NO965445L (no)	1997-06-23
NO305753B1 NO305753B1 (no)	1999-07-19

Family

ID=9485771

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO965445A NO305753B1 (no)	1995-12-21	1996-12-18	Ny 4-imidazolidinonforbindelse, fremgangsmÕte ved dens fremstilling og farmas°ytiske sammensetninger inneholdende den

Country Status (14)

Country	Link
US (1)	US5677325A (no)
EP (1)	EP0780379B1 (no)
JP (1)	JPH09176128A (no)
CN (1)	CN1067381C (no)
AT (1)	ATE165349T1 (no)
AU (1)	AU705695B2 (no)
CA (1)	CA2193310C (no)
DE (1)	DE69600253T2 (no)
DK (1)	DK0780379T3 (no)
ES (1)	ES2118664T3 (no)
FR (1)	FR2742748B1 (no)
NO (1)	NO305753B1 (no)
NZ (1)	NZ299984A (no)
ZA (1)	ZA9610804B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6347197B1 (en) *	2000-10-20	2002-02-12	Lexmark International, Inc.	Life determination in an oil web system
JP3891484B2 (ja) *	2002-09-05	2007-03-14	株式会社ノリタケカンパニーリミテド	電解質膜およびその膜を備えた燃料電池

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4904681A (en) *	1987-12-01	1990-02-27	G. D. Searle & Co.	D-cycloserine and its prodrugs as cognitive enhancers

1995
- 1995-12-21 FR FR9515223A patent/FR2742748B1/fr not_active Expired - Fee Related
1996
- 1996-12-09 DK DK96402661T patent/DK0780379T3/da active
- 1996-12-09 AT AT96402661T patent/ATE165349T1/de not_active IP Right Cessation
- 1996-12-09 DE DE69600253T patent/DE69600253T2/de not_active Expired - Fee Related
- 1996-12-09 ES ES96402661T patent/ES2118664T3/es not_active Expired - Lifetime
- 1996-12-09 EP EP96402661A patent/EP0780379B1/fr not_active Expired - Lifetime
- 1996-12-16 JP JP8335276A patent/JPH09176128A/ja not_active Ceased
- 1996-12-18 NO NO965445A patent/NO305753B1/no unknown
- 1996-12-18 CA CA002193310A patent/CA2193310C/fr not_active Expired - Fee Related
- 1996-12-19 AU AU75479/96A patent/AU705695B2/en not_active Ceased
- 1996-12-20 CN CN96121584A patent/CN1067381C/zh not_active Expired - Fee Related
- 1996-12-20 US US08/770,290 patent/US5677325A/en not_active Expired - Fee Related
- 1996-12-20 NZ NZ299984A patent/NZ299984A/en unknown
- 1996-12-20 ZA ZA9610804A patent/ZA9610804B/xx unknown

Also Published As

Publication number	Publication date
DE69600253T2 (de)	1998-11-12
NO965445D0 (no)	1996-12-18
NO305753B1 (no)	1999-07-19
EP0780379A1 (fr)	1997-06-25
ATE165349T1 (de)	1998-05-15
AU7547996A (en)	1997-06-26
AU705695B2 (en)	1999-05-27
FR2742748B1 (fr)	1998-01-30
US5677325A (en)	1997-10-14
ZA9610804B (en)	1997-06-30
JPH09176128A (ja)	1997-07-08
ES2118664T3 (es)	1998-09-16
NZ299984A (en)	1997-11-24
CN1158847A (zh)	1997-09-10
FR2742748A1 (fr)	1997-06-27
CA2193310A1 (fr)	1997-06-22
CN1067381C (zh)	2001-06-20
EP0780379B1 (fr)	1998-04-22
CA2193310C (fr)	2001-08-14
DE69600253D1 (de)	1998-05-28
DK0780379T3 (da)	1999-01-25

Similar Documents

Publication	Publication Date	Title
AU560809B2 (en)	1987-04-16	Xanthine derivatives
NO173446C (no)	1993-12-15	Analogifremgangsmaate til fremstilling av nye, terapeutisk aktive, substituerte alkandifosfonsyrer
EP0368388A3 (en)	1991-07-17	3-Piperidinyl-1,2-benzisoxazoles
ES2054826T3 (es)	1994-08-16	Peptidos con actividad inhibidora de colagenasa.
PT96916A (pt)	1991-11-29	Processo para a preparacao de composicoes farmaceuticas contendo um macrolido
DE69327890D1 (de)	2000-03-30	Verfahren zur Herstellung von 2-(un)substituierten 4-Alkylimidazolen
BR9813669A (pt)	2000-12-12	Mistura fungicida, e, processo para controlar fungos nocivos
MX9300875A (es)	1993-08-31	Procedimiento para la preparacion de compuestos azabiciclicos.
ATE41772T1 (de)	1989-04-15	Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
LV11689A (lv)	1997-02-20	4-Ú(2-benzotiazolil)metilamino¾-alfa-Ú(3,4-difluorfenoksi)metil¾-1-piperidinetanols
NO305753B1 (no)	1999-07-19	Ny 4-imidazolidinonforbindelse, fremgangsmÕte ved dens fremstilling og farmas°ytiske sammensetninger inneholdende den
ES2030242T3 (es)	1992-10-16	Procedimiento para la obtencion de cetonas alfa, beta-insaturadas.
HU903092D0 (en)	1990-09-28	Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
PT80791A (fr)	1985-08-01	Procede de preparation de nouvelles phenyl-naphtiridines utiles notamment comme medicaments anti-ulceres
AU640723B2 (en)	1993-09-02	2-formylbenzylphosphonic acid derivatives, their preparation and their use for the treatment of diseases caused by viruses
DK232883D0 (da)	1983-05-24	Fremgangsmade til fremstilling af optisk aktive imidazolylpropanolforbindelser
NO20013464L (no)	2001-09-12	Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
ATE60048T1 (de)	1991-02-15	Aminoverbindungen und diese enthaltende fungizide.
DE3469527D1 (en)	1988-04-07	Nortropine derivative, process for its preparation and its use
SE8203245L (sv)	1982-11-28	Forfarande for enantioselektiv framstellning av n-substituerade prolinderivat
DK1098901T3 (da)	2003-05-05	Nye 6-deoxyerythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
DE69622393D1 (de)	2002-08-22	Neue verwendung von pyrazolopyridinverbindungen
ES8304546A1 (es)	1983-03-01	Un procedimiento de preparacion de zomepirac y sus analogos.